SecSonar.com

Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Ironwood Pharmaceuticals, Inc. (IRWD) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $582M. Revenue declined 15.7% year-over-year and the company generated $127M in free cash flow. This page tracks IRWD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 253 employees · IPO Feb 3, 2010

Valuation

Valuation & price

$3.58 · as of May 17, 2026 · -33.6% vs 52w high

26.5

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.31$3.00$0.69Jul 25Dec 25Jun 26Jul 7, 25$0.71Jul 9, 25$0.80Jul 11, 25$0.75Jul 15, 25$0.69Jul 17, 25$0.79Jul 21, 25$0.76Jul 23, 25$0.87Jul 25, 25$0.82Jul 29, 25$0.89Jul 31, 25$0.76Aug 4, 25$0.75Aug 6, 25$0.81Aug 8, 25$0.90Aug 12, 25$0.98Aug 14, 25$1.07Aug 18, 25$1.13Aug 20, 25$1.10Aug 22, 25$1.27Aug 27, 25$1.26Aug 29, 25$1.32Sep 3, 25$1.24Sep 5, 25$1.16Sep 9, 25$1.11Sep 11, 25$1.24Sep 15, 25$1.28Sep 17, 25$1.28Sep 19, 25$1.41Sep 23, 25$1.39Sep 25, 25$1.27Sep 29, 25$1.42Oct 1, 25$1.46Oct 3, 25$1.55Oct 7, 25$1.52Oct 9, 25$1.77Oct 13, 25$1.48Oct 16, 25$1.55Oct 20, 25$1.54Oct 22, 25$1.57Oct 24, 25$1.66Oct 28, 25$1.54Oct 30, 25$1.50Nov 3, 25$1.86Nov 5, 25$2.06Nov 7, 25$1.92Nov 11, 25$2.89Nov 13, 25$3.37Nov 17, 25$3.13Nov 19, 25$3.18Nov 21, 25$3.16Nov 25, 25$3.13Nov 28, 25$3.50Dec 2, 25$3.50Dec 5, 25$3.48Dec 9, 25$3.61Dec 11, 25$3.68Dec 15, 25$3.59Dec 17, 25$3.37Dec 19, 25$3.13Dec 23, 25$3.21Dec 26, 25$3.20Dec 30, 25$3.33Jan 2, 26$4.27Jan 6, 26$4.30Jan 8, 26$3.98Jan 12, 26$4.47Jan 14, 26$4.54Jan 16, 26$4.50Jan 21, 26$5.31Jan 23, 26$5.23Jan 28, 26$4.79Jan 30, 26$4.89Feb 3, 26$4.79Feb 5, 26$4.45Feb 9, 26$4.84Feb 11, 26$4.44Feb 13, 26$4.50Feb 18, 26$4.78Feb 20, 26$3.96Feb 24, 26$3.79Feb 26, 26$3.66Mar 2, 26$3.57Mar 4, 26$3.74Mar 6, 26$3.50Mar 10, 26$3.70Mar 12, 26$3.38Mar 16, 26$3.37Mar 19, 26$3.23Mar 23, 26$3.29Mar 25, 26$3.19Mar 27, 26$3.06Mar 31, 26$3.51Apr 2, 26$3.54Apr 7, 26$3.46Apr 9, 26$3.60Apr 13, 26$3.65Apr 15, 26$4.37Apr 17, 26$4.43Apr 21, 26$4.07Apr 23, 26$3.79Apr 27, 26$4.04Apr 29, 26$4.15May 1, 26$4.44May 5, 26$4.67May 8, 26$4.22May 12, 26$4.09May 14, 26$3.67May 18, 26$3.50May 20, 26$3.92May 22, 26$3.92May 27, 26$3.71May 29, 26$3.57Jun 2, 26$3.28Jun 4, 26$3.40Jun 8, 26$3.29Jun 10, 26$3.35Jun 12, 26$3.65Jun 16, 26$3.66Jun 18, 26$3.54Jun 23, 26$3.86Jun 29, 26$4.20
$0.6952-week range$5.39
Loading valuation history…

Fundamentals

Key fundamentals

$582M

Market cap

-15.7%

Revenue growth (YoY)

100.0%

Gross margin

$127M

Free cash flow (USD)

$382.3M

Net debt

2.0%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$274.0MFY 2017$298.3MFY 2018$346.6MFY 2019$428.4MFY 2020$389.5MFY 2021$413.8MFY 2022$410.6MFY 2023$442.7MFY 2024$351.4MFY 2025$296.2M
$274M$296.2M

Free cash flow by year

2016 → 2025

FY 2016$-129.6MFY 2017$-103.8MFY 2018$-79.5MFY 2019$3.5MFY 2020$167.0MFY 2021$261.6MFY 2022$273.6MFY 2023$183.2MFY 2024$103.4MFY 2025$127.0M
-$129.6M$127M

Gross margin by year

2021 → 2025

FY 202183.0%FY 202299.7%FY 202398.6%FY 202497.8%FY 2025100.0%
83.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • 8-K eventDebt RepaymentJun 15, 2026Filing
  • 8-K eventInterim CFO CompensationMay 21, 2026Filing
  • 8-K eventCFO ResignationMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Ironwood Pharmaceuticals, Inc.'s market cap?

Ironwood Pharmaceuticals, Inc. (IRWD) has a market capitalization of $582M.

What is IRWD's P/E ratio?

IRWD trades at a price-to-earnings ratio of 26.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying IRWD stock?

SEC Form 4 filings show no open-market insider buys at Ironwood Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

TLRY

Tilray Brands, Inc.

$667.2M

CGC

Canopy Growth Corporation

$468.3M

KMDA

Kamada Ltd.

$451.4M

EOLS

Evolus, Inc.

$434.3M

AQST

Aquestive Therapeutics, Inc.

$404.7M

SNDL

SNDL Inc.

$383.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.